Alterations in c‐myc expression in relation to maturational status of human colon carcinoma cells

Kathleen M. Mulder, Michael G. Brattain

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Previous work from this laboratory established a large bank of human colon carcinoma cell lines in culture and classified them with respect to growth regulatory phenotypes based on several biological and biochemical characteristics. In the present report, Northern analysis indicates that addition of the maturational agent N,N‐dimethylformamide (DMF) (1.0%) to proliferating HCT 116 and MOSER cells resulted in a repression of c‐myc proto‐oncogene expression; retinoic acid (1.0 μM) was less effective in this regard. Repression of c‐myc expression by DMF was observed in MOSER and HCT 116 cells, whether it was added to proliferating or late log phase cultures, and was associated with a corresponding reduction in cellular proliferation. The reduction in c‐myc expression by DMF did not require new protein synthesis and occurred within a few minutes after its addition, resulting in a 70% reduction within approximately 2 hr. Previous work from this laboratory indicated that transforming growth factor‐β (TGF‐β) elicited alterations in MOSER cells similar to those observed following DMF treatment. The present report demonstrates that proliferating, but not late log phase, MOSER cells responded to TGF‐β with a repression of c‐myc expression. Similarly, an inhibition of cellular proliferation was only observed when TGF‐β (10 ng/ml) was added to proliferating cells. Collectively, these findings indicate that repression of c‐myc expression is associated with diminished cellular proliferation and the induction of a more benign phenotype in human colon carcinoma cells. Furthermore, this report is the first demonstration of a c‐myc response to TGF‐β in an epithelial cell line.

Original languageEnglish (US)
Pages (from-to)64-70
Number of pages7
JournalInternational Journal of Cancer
Volume42
Issue number1
DOIs
StatePublished - Jul 15 1988

Fingerprint

Transforming Growth Factors
Colon
HCT116 Cells
Carcinoma
Cell Proliferation
Phenotype
Cell Line
Tretinoin
Epithelial Cells
Growth
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{770b1bb21c814c56a87d5a3d8c9a46e4,
title = "Alterations in c‐myc expression in relation to maturational status of human colon carcinoma cells",
abstract = "Previous work from this laboratory established a large bank of human colon carcinoma cell lines in culture and classified them with respect to growth regulatory phenotypes based on several biological and biochemical characteristics. In the present report, Northern analysis indicates that addition of the maturational agent N,N‐dimethylformamide (DMF) (1.0{\%}) to proliferating HCT 116 and MOSER cells resulted in a repression of c‐myc proto‐oncogene expression; retinoic acid (1.0 μM) was less effective in this regard. Repression of c‐myc expression by DMF was observed in MOSER and HCT 116 cells, whether it was added to proliferating or late log phase cultures, and was associated with a corresponding reduction in cellular proliferation. The reduction in c‐myc expression by DMF did not require new protein synthesis and occurred within a few minutes after its addition, resulting in a 70{\%} reduction within approximately 2 hr. Previous work from this laboratory indicated that transforming growth factor‐β (TGF‐β) elicited alterations in MOSER cells similar to those observed following DMF treatment. The present report demonstrates that proliferating, but not late log phase, MOSER cells responded to TGF‐β with a repression of c‐myc expression. Similarly, an inhibition of cellular proliferation was only observed when TGF‐β (10 ng/ml) was added to proliferating cells. Collectively, these findings indicate that repression of c‐myc expression is associated with diminished cellular proliferation and the induction of a more benign phenotype in human colon carcinoma cells. Furthermore, this report is the first demonstration of a c‐myc response to TGF‐β in an epithelial cell line.",
author = "Mulder, {Kathleen M.} and Brattain, {Michael G.}",
year = "1988",
month = "7",
day = "15",
doi = "10.1002/ijc.2910420113",
language = "English (US)",
volume = "42",
pages = "64--70",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Alterations in c‐myc expression in relation to maturational status of human colon carcinoma cells. / Mulder, Kathleen M.; Brattain, Michael G.

In: International Journal of Cancer, Vol. 42, No. 1, 15.07.1988, p. 64-70.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alterations in c‐myc expression in relation to maturational status of human colon carcinoma cells

AU - Mulder, Kathleen M.

AU - Brattain, Michael G.

PY - 1988/7/15

Y1 - 1988/7/15

N2 - Previous work from this laboratory established a large bank of human colon carcinoma cell lines in culture and classified them with respect to growth regulatory phenotypes based on several biological and biochemical characteristics. In the present report, Northern analysis indicates that addition of the maturational agent N,N‐dimethylformamide (DMF) (1.0%) to proliferating HCT 116 and MOSER cells resulted in a repression of c‐myc proto‐oncogene expression; retinoic acid (1.0 μM) was less effective in this regard. Repression of c‐myc expression by DMF was observed in MOSER and HCT 116 cells, whether it was added to proliferating or late log phase cultures, and was associated with a corresponding reduction in cellular proliferation. The reduction in c‐myc expression by DMF did not require new protein synthesis and occurred within a few minutes after its addition, resulting in a 70% reduction within approximately 2 hr. Previous work from this laboratory indicated that transforming growth factor‐β (TGF‐β) elicited alterations in MOSER cells similar to those observed following DMF treatment. The present report demonstrates that proliferating, but not late log phase, MOSER cells responded to TGF‐β with a repression of c‐myc expression. Similarly, an inhibition of cellular proliferation was only observed when TGF‐β (10 ng/ml) was added to proliferating cells. Collectively, these findings indicate that repression of c‐myc expression is associated with diminished cellular proliferation and the induction of a more benign phenotype in human colon carcinoma cells. Furthermore, this report is the first demonstration of a c‐myc response to TGF‐β in an epithelial cell line.

AB - Previous work from this laboratory established a large bank of human colon carcinoma cell lines in culture and classified them with respect to growth regulatory phenotypes based on several biological and biochemical characteristics. In the present report, Northern analysis indicates that addition of the maturational agent N,N‐dimethylformamide (DMF) (1.0%) to proliferating HCT 116 and MOSER cells resulted in a repression of c‐myc proto‐oncogene expression; retinoic acid (1.0 μM) was less effective in this regard. Repression of c‐myc expression by DMF was observed in MOSER and HCT 116 cells, whether it was added to proliferating or late log phase cultures, and was associated with a corresponding reduction in cellular proliferation. The reduction in c‐myc expression by DMF did not require new protein synthesis and occurred within a few minutes after its addition, resulting in a 70% reduction within approximately 2 hr. Previous work from this laboratory indicated that transforming growth factor‐β (TGF‐β) elicited alterations in MOSER cells similar to those observed following DMF treatment. The present report demonstrates that proliferating, but not late log phase, MOSER cells responded to TGF‐β with a repression of c‐myc expression. Similarly, an inhibition of cellular proliferation was only observed when TGF‐β (10 ng/ml) was added to proliferating cells. Collectively, these findings indicate that repression of c‐myc expression is associated with diminished cellular proliferation and the induction of a more benign phenotype in human colon carcinoma cells. Furthermore, this report is the first demonstration of a c‐myc response to TGF‐β in an epithelial cell line.

UR - http://www.scopus.com/inward/record.url?scp=2442589157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442589157&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910420113

DO - 10.1002/ijc.2910420113

M3 - Article

C2 - 3164710

AN - SCOPUS:2442589157

VL - 42

SP - 64

EP - 70

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -